கிரிஸ்டினா கோவல்க்ஜிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிரிஸ்டினா கோவல்க்ஜிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிரிஸ்டினா கோவல்க்ஜிக் Today - Breaking & Trending Today

OncoBay Clinical Announces Technology Partnership with Protocol First


OncoBay Clinical Announces Technology Partnership with Protocol First
OncoBay Adopts Protocol First Technology Solutions to Further Simplify the Complex
News provided by
Share this article
TAMPA, Fla. and SALT LAKE CITY, May 11, 2021 /PRNewswire/
OncoBay Clinical Inc., a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership with
Protocol First, Inc., a software solutions provider focused on accelerating clinical research. The partnership combines OncoBay s industry leading oncology operations with Protocol First s world class proprietary Clinical Pipe software to integrate data from leading EHR systems into electronic data capture (EDC). The adoption of Clinical Pipe allows OncoBay to further simplify complex oncology trials by improving data quality, reducing data entry timelines, reducing queries as well as the need for on-site monitoring vis ....

Salt Lake City , United States , Krystyna Kowalczyk , Hughp Levaux , Krystyna Kowalczykpresident , Protocol First Inc , Moffitt Cancer Center , Oncobay Clinical Inc , Life Sciences , Bay Clinical Inc , Protocol First , Clinical Pipe , Bay Clinical , Source Upload , Medidata Rave , Oracle Inform , உப்பு ஏரி நகரம் , ஒன்றுபட்டது மாநிலங்களில் , கிரிஸ்டினா கோவல்க்ஜிக் , ப்ரோடொகால் முதல் இன்க் , மாஃபிட் புற்றுநோய் மையம் , வாழ்க்கை அறிவியல் , ப்ரோடொகால் முதல் , மருத்துவ குழாய் , வளைகுடா மருத்துவ , மூல பதிவேற்றவும் ,

TrialJectory Achieves 500 Percent Year-Over-Year Growth as Cancer Patients and Pharmaceutical Industry Increasingly Leverage Proprietary AI Platform in COVID-19 Pandemic


Share this article
Share this article
NEW YORK, March 9, 2021 /PRNewswire/ TrialJectory ( the Company ), an artificial intelligence-powered digital health platform that empowers cancer patients to find advanced treatment options and enables the pharmaceutical industry to effectively design and recruit for clinical trials, announced today that it has experienced 500 percent year-over-year growth in new patient users, with approximately 3,000 new patients signing up each month. Over the same period, TrialJectory experienced a significant increase in strategic collaborations with pharmaceutical companies and contract research organizations (CROs). To support the Company s current and expected growth, TrialJectory recently completed a Series A financing round, led by Contour Venture Partners, with equal participation from Rho Ventures. Connecticut Innovations and TIA Ventures also participated in the $5 million round. To date, TrialJectory has raised approximately $8 millio ....

United States , Tzvia Bader , Krystyna Kowalczyk , Bob Greene , Prnewswire Trialjectory The Company , Contour Venture Partners , Connecticut Innovations , Oncobay President , ஒன்றுபட்டது மாநிலங்களில் , கிரிஸ்டினா கோவல்க்ஜிக் , பாப் கிரீன் , விளிம்பு துணிகர கூட்டாளர்கள் , கனெக்டிகட் புதுமைகள் ,

AiCure and OncoBay Clinical Partner to Improve Oncology Clinical Trials and Patient Care

AiCure and OncoBay Clinical Partner to Improve Oncology Clinical Trials and Patient Care
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

Krystyna Kowalczyk , Ed Ikeguchi , Moffitt Cancer Center , Bay Clinical , Patient Connect , கிரிஸ்டினா கோவல்க்ஜிக் , மாஃபிட் புற்றுநோய் மையம் , வளைகுடா மருத்துவ , நோயாளி இணைக்கவும் ,

CROs partner on women's oncology clinical solutions


CROs partner on women’s oncology clinical solutions
Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for women’s cancers.
Health Decisions is a contract research organization (CRO) honed in on women’s health clinical research, and diagnostic and device development; OncoBayClinical tackles complex, early-phase oncology programs. Together, the two CROs will harness expertise in women’s health and oncology to bolster clinical programs for sponsors seeking novel treatment options in women’s cancers.
Patrick Phillips, Health Decisions CEO, told Outsourcing-Pharma that women historically are underrepresented in clinical research, even in trials investigating treatments specifically for women. ....

Krystyna Kowalczyk , Patrick Phillips , Health Decisions , Journal Of The American College Cardiology , American College , Oncobay Clinical , கிரிஸ்டினா கோவல்க்ஜிக் , பேட்ரிக் பிலிப்ஸ் , ஆரோக்கியம் முடிவுகள் , இதழ் ஆஃப் தி அமெரிக்கன் கல்லூரி இருதயவியல் , அமெரிக்கன் கல்லூரி ,